Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elagolix vs OCPs for Endometriosis Associated Pelvic Pain
NCT07532876Phase 4Enrolling by invitation
- Sponsor
- Pak Emirates Military Hospital
- Start
- May 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of elagolix in endometriosis, sponsored by Pak Emirates Military Hospital. Started May 2026; status: enrolling by invitation.
02
Drugs
elagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT07532876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07532876.